Canada’s largest pharmacy locks up more medical cannabis supply

Be at the forefront of cannabis and psychedelics science and innovation. Register today & Save $200 on tickets to The Emerald Conference by MJBiz Science, April 1-3 in San Diego.

Canada’s largest pharmacy chain signed up another major supplier of medical marijuana, further cementing what analysts called the “groundbreaking” entry of traditional pharmacies into the MMJ industry earlier this month.

The latest deal has Shoppers Drug Mart entering an agreement to obtain an undisclosed amount of medical cannabis from MedReleaf Corp.

MedReleaf, based in Markham and traded on the Toronto Stock Exchange under the symbol LEAF, will supply its branded cannabis products to Shoppers, which is expected to sell the products through its online pharmacy — pending approval from Health Canada.

Earlier this month, Aphria signed a deal to supply medical cannabis, including leaf and oil, for Toronto-based Shoppers.

Lovell Drugs, Ontario’s oldest pharmacy chain, also got into the MMJ market by signing an exclusive deal with Toronto-based Maricann Group.

And CanniMed Therapeutics entered into a definitive agreement with PharmaChoice to supply medical cannabis products to its 750 pharmacy locations across Canada.

The deals could breathe fresh life into the growth of the medical marijuana market in Canada, which has seen slowing growth in patient registrants since late 2016.

Canada recorded its 200,000th patient in June, up from 75,000 one year earlier.

Matt Lamers can be reached at

To sign up for our weekly Canada marijuana business newsletter, click here.